SCHEMBL7254798

SCHEMBL7254798

CC(C)CNc1nc(Cl)nc2cc(Cl)ccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.49
▸ ACP1 P24666 1/20 0.46
▸ MAP4K4 O95819 1/20 0.44
▸ TLR7 Q9NYK1 1/20 0.44
▸ LATS1 O95835 1/20 0.43
▸ LATS2 Q9NRM7 1/20 0.43
▸ APP P05067 3/20 0.42
▸ PDE5A O76074 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ CNR1 P21554 1/20 0.40
▸ CNR2 P34972 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ NR4A2 P43354 1/20 0.39
▸ HRH4 Q9H3N8 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PPARG P37231 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ NR2E3 Q9Y5X4 1/20 0.38
▸ NCOR2 Q9Y618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21055788 0.78 HRH4 (0.57) POLBNR4A2HRH4MEN1KMT2A
SCHEMBL11815143 0.76 ESR1 (0.47) ESR1ACP1MAP4K4TLR7LATS1
SCHEMBL21055802 0.75 PDE5A (0.76) APPPDE5AHRH4MEN1KMT2A
SCHEMBL7254571 0.73 CNR1 (0.52) CNR1HTT
SCHEMBL3110406 0.73 HTT (0.70) ACP1APPPDE5APOLBHTT
SCHEMBL7254554 0.72 CNR1 (0.56) APPPDE5ACNR1CNR2HTT
SCHEMBL25287893 0.71 CSNK2A1 (0.45) TLR7HTT
SCHEMBL3711032 0.71 ESR1 (0.45) ESR1ACP1MAP4K4TLR7LATS1
SCHEMBL1461282 0.71 GSK3B (0.54) MAP4K4CNR1CNR2
SCHEMBL4269216 0.70 CYP2D6 (0.63) TLR7APPPOLBHTTNR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055866-A1 QUINAZOLINE AND QUINOLINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-10 — — WO disclosed
Send feedback